Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Dicle Buyuktaskin, Esra Guney, Ozlem Gulbahar, Ahmet Ozaslan & Burak Arslan. (2022) Serum ciliary neurotrophic factor levels in children with attention deficit hyperactivity disorder. International Journal of Neuroscience 0:0, pages 1-5.
Read now
Read now
Nihal Yurteri, İbrahim Ethem Şahin & Ali Evren Tufan. (2019) Altered serum levels of vascular endothelial growth factor and glial-derived neurotrophic factor but not fibroblast growth factor-2 in treatment-naive children with attention deficit/hyperactivity disorder. Nordic Journal of Psychiatry 73:4-5, pages 302-307.
Read now
Read now
Annette Conzelmann, Stefan Müller, Thomas Jans, Götz-Erik Trott, Thomas Keil, Manfred Gerlach & Tobias J. Renner. (2019) Long-term cardiovascular safety of psychostimulants in children with attention deficit hyperactivity disorder. International Journal of Psychiatry in Clinical Practice 23:2, pages 157-159.
Read now
Read now
Articles from other publishers (30)
Mustafa Esad Tezcan, Cüneyt Uğur, Ümmügülsüm Can, Ekrem Furkan Uçak, Fatih Ekici, Fahrettin Duymuş & Agah Tuğrul Korucu. (2024) Are decreased cocaine- and amphetamine regulated transcript and Agouti- related peptide levels associated Eating behavior in medication-free children with attention deficit and hyperactivity disorder?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 129, pages 110907.
Crossref
Crossref
Marina Silva de Lucca, Maria Eduarda Oliveira Pimentel, Cleuberton Kenedy Oliveira Raimundo, Bruno David Henriques, Tiago Ricardo Moreira, Sílvia Almeida Cardoso & Débora Marques de Miranda. (2023) Brain-derived neurotrophic factor (BDNF) levels in children and adolescents before and after stimulant use a systematic review and metanalysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 125, pages 110761.
Crossref
Crossref
Nilifer Gürbüzer, Hacer Akgül Ceyhun, Nurinnisa Öztürk & Kamber Kasali. (2023) The Relationship Between Eating-Attitudes and Clinical Characteristics, Agouti-Related Peptide, and Other Biochemical Markers in Adult-Attention Deficit Hyperactivity Disorder. Journal of Attention Disorders 27:4, pages 394-409.
Crossref
Crossref
AnaPaula de A. Boleti, PedroHenrique de O. Cardoso, BrenoEmanuel F. Frihling, PatríciaSouza e Silva, LuizFilipe R. N. de Moraes & Ludovico Migliolo. (2023) Adipose tissue, systematic inflammation, and neurodegenerative diseases. Neural Regeneration Research 18:1, pages 38.
Crossref
Crossref
Cavithan Gumus, Ipek Percinel Yazici, Kemal Utku Yazici & Bilal Ustundag. (2022) Increased Serum Brain-derived Neurotrophic Factor, Nerve Growth Factor, Glial-derived Neurotrophic Factor and Galanin Levels in Children with Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment. Clinical Psychopharmacology and Neuroscience 20:4, pages 635-648.
Crossref
Crossref
Anne-Sophie Weyns, Annelies A.J. Verlaet, Maxim Van Herreweghe, Annelies Breynaert, Erik Fransen, Ingrid De Meester, Emilie Logie, Wim Vanden Berghe, Helene Verhelst, Dirk Van West, Ingrid Van Ingelghem, An I. Jonckheere, Diane Beysen, Sandra Kenis, Els Moens, Aalt P.J. van Roest, Huub F.J. Savelkoul, Tess De Bruyne, Luc Pieters, Berten Ceulemans & Nina Hermans. (2022) Clinical Investigation of French Maritime Pine Bark Extract on Attention-Deficit Hyperactivity Disorder as compared to Methylphenidate and Placebo: Part 2: Oxidative Stress and Immunological Modulation. Journal of Functional Foods 97, pages 105247.
Crossref
Crossref
Maria de los Angeles Robinson-Agramonte, Bernadeta Michalski, Belkis Vidal-Martinez, Leyanis Ramos Hernández, Mabel Whilby Santiesteban & Margaret Fahnestock. (2022) BDNF, proBDNF and IGF-1 serum levels in naïve and medicated subjects with autism. Scientific Reports 12:1.
Crossref
Crossref
Thais Martins-Silva, Juliana dos Santos Vaz, Julia Luiza Schäfer, Giovanni Abrahão Salum, Marina Xavier Carpena, Eduardo Schneider Vitola, Vitor Breda, Eugênio Horacio Grevet, Christian Loret de Mola, Fernando Barros, Ana Maria Baptista Menezes, Helen Gonçalves, Fernando C. Wehrmeister, Luis Augusto Rohde & Luciana Tovo-Rodrigues. (2022) ADHD in childhood predicts BMI and body composition measurements over time in a population-based birth cohort. International Journal of Obesity 46:6, pages 1204-1211.
Crossref
Crossref
Hayley Dingsdale, Samantha M. Garay, Hannah R. Tyson, Katrina A. Savory, Lorna A. Sumption, Jemima S. Kelleher, Kate Langley, Stephanie Van Goozen & Rosalind M. John. (2022) Cord serum brain-derived neurotrophic factor levels at birth associate with temperament outcomes at one year. Journal of Psychiatric Research 150, pages 47-53.
Crossref
Crossref
Yoojeong Lee, Nayeong Kong, San Koo, Dai Seg Bai, Hee jin Kim, Hyunseok Jeong & Wan Seok Seo. (2022) A 24-Month Effects of Methylphenidate Use on Growth in Children and Adolescents With Attention Deficit Hyperactivity Disorder. Psychiatry Investigation 19:3, pages 213-219.
Crossref
Crossref
Serena Camuso, Piergiorgio La Rosa, Maria Teresa Fiorenza & Sonia Canterini. (2022) Pleiotropic effects of BDNF on the cerebellum and hippocampus: Implications for neurodevelopmental disorders. Neurobiology of Disease 163, pages 105606.
Crossref
Crossref
Magdalena Sustkova-Fiserova, Chrysostomos Charalambous, Anna Khryakova, Alina Certilina, Marek Lapka & Romana Šlamberová. (2022) The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions. International Journal of Molecular Sciences 23:2, pages 761.
Crossref
Crossref
Reem El Ghamry, Mona El-Sheikh, Marwa Abdel Meguid, Safi Nagib & Dina Aly El Gabry. (2021) Plasma brain-derived neurotrophic factor (BDNF) in Egyptian children with attention deficit hyperactivity disorder. Middle East Current Psychiatry 28:1.
Crossref
Crossref
Luis Núñez-Jaramillo, Andrea Herrera-Solís & Wendy Verónica Herrera-Morales. (2021) ADHD: Reviewing the Causes and Evaluating Solutions. Journal of Personalized Medicine 11:3, pages 166.
Crossref
Crossref
Kanchana KoonrungsesomboonNut Koonrungsesomboon. (2020) The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 30:3, pages 189-197.
Crossref
Crossref
Luisa Fernández-LópezAntonio Molina-CarballoIsabel Cubero-MillánAna Checa-RosIrene Machado-CasasEnrique Blanca-JoverAntonio Jerez-CaleroYolanda Madrid-FernándezJosé UberosAntonio Muñoz-Hoyos. (2020) Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology. Journal of Child and Adolescent Psychopharmacology 30:3, pages 177-188.
Crossref
Crossref
Tyler Stevens, Katrin Sangkuhl, Jacob T. Brown, Russ B. Altman & Teri E. Klein. (2019) PharmGKB summary. Pharmacogenetics and Genomics 29:6, pages 136-154.
Crossref
Crossref
Eleni Pilitsi, Olivia M. Farr, Stergios A. Polyzos, Nikolaos Perakakis, Eric Nolen-Doerr, Aimilia-Eirini Papathanasiou & Christos S. Mantzoros. (2019) Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism 92, pages 170-192.
Crossref
Crossref
Saliha Baykal, Yakup Albayrak, Ferit Durankuş, Savaş Güzel, Özlem Abbak, Nihan Potas, Murat Beyazyüz, Koray Karabekiroğlu & Mustafa Metin Donma. (2019) Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder. Neurological Sciences 40:3, pages 593-602.
Crossref
Crossref
Ole Jakob Storebø, Nadia Pedersen, Erica Ramstad, Maja Laerke Kielsholm, Signe Sofie Nielsen, Helle B Krogh, Carlos R Moreira-Maia, Frederik L Magnusson, Mathilde Holmskov, Trine Gerner, Maria Skoog, Susanne Rosendal, Camilla Groth, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Sasja J Håkonsen, Lise Aagaard, Erik Simonsen & Christian Gluud. (2018) Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Farnaz Torabi, Abolfazl Farahani, Sepide Safakish, Azam Ramezankhani & Firouzeh Dehghan. (2018) Evaluation of motor proficiency and adiponectin in adolescent students with attention deficit hyperactivity disorder after high-intensity intermittent training. Psychiatry Research 261, pages 40-44.
Crossref
Crossref
Jian Zhang, Wanjun Luo, Qiyang Li, Ruoting Xu, Qiqiong Wang & Qitao Huang. (2018) Peripheral brain-derived neurotrophic factor in attention-deficit/hyperactivity disorder: A comprehensive systematic review and meta-analysis. Journal of Affective Disorders 227, pages 298-304.
Crossref
Crossref
Aynur Pekcanlar Akay, Halil Resmi, Sevay Alsen Güney, Handan Özek Erkuran, Gonca Özyurt, Enis Sargin, Ahmet Topuzoglu & Ali Evren Tufan. (2017) Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest–posttest study. European Child & Adolescent Psychiatry 27:1, pages 127-135.
Crossref
Crossref
R. Bou Khalil, N. Fares, Y. Saliba, J. Tamraz & S. Richa. (2017) L’effet de la méthylphénidate sur l’appétit et le poids. L'Encéphale 43:6, pages 577-581.
Crossref
Crossref
Murat Coskun & Ibrahim Adak. (2017) Excessive and Frequent Menstrual Bleeding With Methylphenidate in an Adolescent Girl With Attention-Deficit Hyperactivity Disorder. Journal of Clinical Psychopharmacology 37:5, pages 637-639.
Crossref
Crossref
Shih-Jen Tsai. (2017) Role of neurotrophic factors in attention deficit hyperactivity disorder. Cytokine & Growth Factor Reviews 34, pages 35-41.
Crossref
Crossref
Isabel Cubero-Millán, María-José Ruiz-Ramos, Antonio Molina-Carballo, Sylvia Martínez-Serrano, Luisa Fernández-López, Irene Machado-Casas, Pilar Tortosa-Pinto, Aida Ruiz-López, Juan-de-Dios Luna-del-Castillo, José Uberos & Antonio Muñoz-Hoyos. (2016) BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology. Psychopharmacology 234:2, pages 267-279.
Crossref
Crossref
Adelle M. CadieuxAdelle M. Cadieux. 2017. Assessing and Treating Pediatric Obesity in Neurodevelopmental Disorders. Assessing and Treating Pediatric Obesity in Neurodevelopmental Disorders
85
104
.
Caner MutluKayhan BahalıHatice GunesHilal Adaletli. (2016) Increase in Menstrual Cycle Length Induced by Extended-Release Methylphenidate in an Adolescent with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 26:9, pages 860-861.
Crossref
Crossref
Caroline Davis, Robert D. Levitan, Allan S. Kaplan, Jacqueline C. Carter-Major & James L. Kennedy. (2016) Sex differences in subjective and objective responses to a stimulant medication (methylphenidate): Comparisons between overweight/obese adults with and without binge-eating disorder. International Journal of Eating Disorders 49:5, pages 473-481.
Crossref
Crossref